Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LJ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LJ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LE.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LE.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MD.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MD.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
MD.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LE.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LE.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LE.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDQNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDQNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.502NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.502NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.502NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.285NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.285NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.285NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.582NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.582NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.582NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.580NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.580NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.580NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.306NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.306NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.306NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.280NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.280NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.280NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.329NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.329NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.329NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.396NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.396NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.396NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.595.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.595.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used